Chronic Disease Treatment & Management

Chronic disease management links recurring medicine demand, implanted devices, monitoring and ongoing clinical care. This basket combines those businesses rather than concentrating on experimental drug pipelines or a single treatment class. With AI spending under scrutiny, it offers a different demand driver, while remaining exposed to reimbursement pressure, clinical competition and healthcare policy risk. Launch basket (equal weight): MDT, UNH, JNJ, ABBV, AMGN, LLY, DXCM, ABT Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.